Cytokines Modulators in Plants. Chemical and Therapeutics Studies

Table of Contents

Introduction

Review of literature

I- Immunomodulators

II- Immunomodulatory plants

III- Immunomodulatory natural products

IV- Semisynthetic glycyrrhetinic acid derivatives

VI- Conclusion

Material and methods:

Material

Methods

I- Plant material

II- Biological assays

III- Semisynthesis of 18-β-Glycyrrhetinic acid derivatives

Results and discussion

I- Extraction

II- Fractionation

III- Semisynthetic derivatization

IV- Lymphocyte transformation assay

IV- Other biological bioassays

V- Isolation and semi-synthesis

Summary and conclusion

Research Objectives and Focus

The primary objective of this thesis is to screen various medicinal plants for potential immunomodulatory effects, specifically targeting the identification of major active fractions. Furthermore, the research aims to perform structural modifications on key bioactive components via semisynthetic derivatization to gain insight into the structural requirements for immunomodulatory activity, while also evaluating these natural and modified compounds for antioxidant and anti-proliferative mechanisms.

• Screening of traditionally used plants for immune-enhancing properties.
• Semisynthetic modification of 18-β-glycyrrhetinic acid derivatives.
• In vitro evaluation of immunomodulatory activity using PBMC transformation assays.
• Assessment of antioxidant capacities using ABTS assays.
• Evaluation of cytotoxic activities against breast, hepatic, and colorectal cancer cell lines.

Excerpt from the Book

Summary of Chapters

Introduction: Provides a comprehensive overview of the human immune system, including its multi-layered defense mechanisms, and introduces the rationale for researching plant-based natural immunomodulators.

Review of literature: Details the definitions, classifications, and biological mechanisms of naturally occurring immunomodulators and lists various in vivo and in vitro testing models.

Material and methods: Documents the sourcing of plant materials and the detailed chemical procedures, including extraction, fractionation, and biological assays like LTA, cytotoxicity, and antioxidant testing.

Results and discussion: Presents the findings of the plant screenings, the chemical synthesis and identification of various glycyrrhetinic acid derivatives, and the analysis of their biological activities.

Summary and conclusion: Synthesizes the results of the study, emphasizing the potential of specific plant extracts and semisynthetic derivatives as effective and safer immunomodulatory agents.

Keywords

Immunomodulators, Glycyrrhiza glabra, 18-β-Glycyrrhetinic acid, Lymphocyte transformation assay, Semisynthesis, PBMC, Antioxidant activity, Cytotoxicity, MTT assay, Natural products, Triterpenoids, Immunostimulants, Immunosuppressants, Pharmacognosy, Structural modification.

Frequently Asked Questions

What is the core focus of this thesis?

This work explores the immunomodulatory potential of various medicinal plants and utilizes chemical synthesis to modify natural compounds to improve their efficacy and understand structural activity relationships.

Which key plant species were investigated?

Key plants studied include Aralia victoria, Boswellia carteri, Cyperus rotundus, Ginkgo biloba, Glycyrrhiza glabra, Olea europaea, and Rosmarinus officinalis, among others.

What is the primary objective regarding glycyrrhetinic acid?

The aim is to synthesize semisynthetic derivatives of 18-β-glycyrrhetinic acid (the aglycone of glycyrrhizin) to enhance therapeutic potency, improve pharmacokinetic profiles, or discover new biological activities.

What scientific methods were employed?

The research employed phytochemical extraction, liquid-liquid fractionation, column chromatography for isolation, and structural elucidation via NMR and FTIR. Biological activity was assessed using LTA, MTT-based cytotoxicity assays, and ABTS antioxidant assays.

What is the clinical relevance of the research?

By identifying natural or modified compounds that modulate the immune system, the research aims to provide safer alternatives to synthetic drugs, especially for patients with immune impairment or those undergoing chemotherapy.

How is the immunomodulatory activity measured?

Activity is measured primarily through a lymphocyte transformation assay (LTA), which assesses the proliferation of human Peripheral Blood Monocytes (PBMC) when stimulated by plant extracts or specific chemical compounds.

What makes compounds J9-J12 and J14 unique in this study?

These specific derivatives are documented as novel compounds synthesized during the study, compared to the other nine known derivatives which served as reference points.

What conclusion did the author reach regarding the antioxidant activity of the derivatives?

The study concluded that the tested glycyrrhetinic acid derivatives exhibited non-significant direct antioxidant power, suggesting that this mechanism is likely not responsible for their observed immunomodulatory effects.